REQUEST A DEMO

New Report: Launch Readiness 2022 - How to address key trends and challenges

Posted by Andre Moa on Feb 1, 2022 10:30:00 AM

In our new report  Launch Readiness 2022, we consider how launch strategists may best navigate a fast-changing yet still commercially ripe environment for pharmaceutical launch readiness. We show how digital transformation and cutting-edge launch management software help companies track the status of launch activities and manage global launch challenges, in real-time and across both functions and countries.

Read More

Topics: launch readiness, launch strategy, launch effectiveness, launch readiness framework, launch plan, pharma tenders

Rethinking Launch Readiness in 2021: The New Normal in the Shadow of COVID

Posted by Andre Moa on Feb 24, 2021 3:50:37 PM

 

It is probably reasonable enough by now to talk about the launch readiness landscape for medicines and vaccines as pre- and post-COVID. We can also say with some certainty that nothing will ever be the same again.

Read More

Topics: launch readiness, launch strategy, launch effectiveness, launch readiness framework, launch plan, pharma tenders

The Ultimate Guide to Launch Readiness in 2019

Posted by Andre Moa on Feb 5, 2019 7:45:00 AM

Pharmaceutical companies have more reasons than ever to hone their launch readiness skills. The question is whether they possess the new product launch strategies and tools to successfully commercialise their new medicines in an often volatile and always competitive global marketplace.  

Read More

Topics: launch readiness, launch strategy, launch effectiveness, launch readiness framework, launch plan, pharma tenders

Launch effectiveness is a patient-access issue

Posted by Andre Moa on May 25, 2017 12:14:00 PM

Access to medicines is a loaded term. In an ideal world, every patient would have unimpeded access to the best drug available. In reality, access is usually selective at best.

Read More

Topics: patient access, launch effectiveness